Michael R. Minogue, CEO, President & Chairman of the Board

Dr. Thorsten Siess, Chief Technology Officer

Mr. Michael R. Minogue joined us as Chief Executive Officer, President and a Director in April 2004 following a twelve-year career at GE Medical Systems. Most recently, Mr. Minogue was Vice President and General Manager of Americas Sales and Marketing for GE Medical Systems Information Technology. From 1998 to 2003 Mr. Minogue held various positions at GE including General Manager for the Global PET Business, General Manager, Americas Cardiology & IT Sales and General Manager, Global Installed Base. Prior to joining GE, Mr. Minogue served on active duty for four years in the U.S. Army as an infantry platoon leader, including completion of Army Ranger training. Mr. Minogue received his Bachelor's degree in Engineering from the United States Military Academy at West Point and his MBA from the University of Chicago.

Dr. Thorsten Siess joined ABIOMED in 2005 upon its acquisition of Impella CardioSystems, AG, which he co-founded in 1998 and has served as Manager of R&D, then Chief Technology Officer. His work in the development and marketing of the Impella LP2.5 and LP5.0 in Europe led to their CE Mark approval. During his time at the University of Aachen he developed the Impella technology which served as a platform for the entire Impella product portfolio. The products, which allow early intervention through a pencil-sized VAD, are now available in over 100 centers in 20 countries around the world. Dr. Siess is leading the effort at ABIOMED to make these products available in the U.S., pending FDA approval. Prior to founding Impella, Dr. Siess served as Scientist in the Biomedical Technology Team at Helmholtz-Institute of Biomedicine at the University of Aachen in Germany. Dr. Siess received a Ph.D. degree as well as his MASc in Mechanical Engineering from the University of Aachen.